Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer." title="" class="btn" data-container="body" data-html="true" data-id="203742" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Hemerion Therapeutics"> 3,352
Activities
Entity types
Location
Lille, France
Lille
France
Employees
Scale: 11-50
Estimated: 16
Engaged catalyst
42Added in Motherbase
1 year, 11 months ago[Automatic translation follows] A new player committed to tackle #glioblastoma and #brain #cancer
Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
A new player committed to tackle #glioblastoma and #brain #cancer
Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Toulouse Tech Transfer | Other 7 Apr 2024 | | |
![]() | SATT Nord | Other 24 Mar 2025 | | |
![]() J'aime les Startups NGO, Think Tank, Technology, Information and Internet | J'aime les Startups NGO, Think Tank, Technology, Information and Internet | Other 12 Oct 2023 | | |
![]() EY Consulting, audit, IT Services and IT Consulting | EY Consulting, audit, IT Services and IT Consulting | Other 28 Sep 2023 | | |
![]() Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 16 Jul 2024 | | |
![]() BNP Paribas Bank, Banking | BNP Paribas Bank, Banking | Other 12 Oct 2023 | | |
![]() Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 24 Mar 2025 | | |
![]() Finovam Gestion Venture Capital and Private Equity Principals | Finovam Gestion Venture Capital and Private Equity Principals | Other 24 Mar 2025 | | |
![]() Région Hauts-de-France National and local authorities, Government Administration | Région Hauts-de-France National and local authorities, Government Administration | Other 29 May 2024 | | |
![]() France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 24 Mar 2025 | |